Y-mAbs Therapeutics
YMAB
YMAB
102 hedge funds and large institutions have $128M invested in Y-mAbs Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
-10
Holders Change %
-8.93%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
17
Increased
40
Reduced
28
Closed
26
Calls
$171K
Puts
$9K
Net Calls
+$162K
Net Calls Change
+$120K
Top Buyers
| 1 |
CP
Caligan Partners
New York
|
$10.4M |
| 2 |
Millennium Management
New York
|
$2.07M |
| 3 |
ACA
Acorn Capital Advisors
New York
|
$14.3M |
| 4 |
Morgan Stanley
New York
|
$2.22M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$1.25M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EBA
126
Eagle Bay Advisors
New York
| – | -$392 | -50 | Closed |
|
|
CIAM
127
Caitong International Asset Management
Hong Kong
| – | -$352 | -45 | Closed |
|
|
GI
128
GAMMA Investing
Foster City,
California
| – | -$258 | -33 | Closed |
|
129
US Bancorp
Minneapolis,
Minnesota
| – | -$180 | -23 | Closed |
|